Record Revenue and Positive EBITDA CALGARY, AB , Aug. 28, 2024 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI , OTCQX: NSCIF , FRA: 1N1 ), a leader in portable NMR machines and MRI technology for industrial and research applications announces second quarter results for the period ending on June 30, 2024 , achieving 65% year-over-year revenue growth to $11.
5 million in Q2. Chief Executive Officer Sean Krakiwsky and Chief Financial Officer Randall McRae will host a conference call at 5 P.M.
Eastern Time today to discuss the results. A second call will be held for European investors at 8:30am Eastern Time tomorrow, August 29 . All interested parties are invited to join these calls.
"We continue to see strength in both of our core business segments, benchtop NMR and security services," said Sean Krakiwsky, Founder and CEO of Nanalysis. "In addition, this quarter we had the added contribution of sizeable medical imaging hardware sales resulting in another record revenue quarter. We are very encouraged by these results which were consistent with our internal expectations, and we have a very positive outlook as we move into the back half of the year, which has historically been stronger than our first half.
While we continue to drive our topline, we remain steadfast on improving margins by leveraging efficiencies and reducing costs, with the ultimate goal of delivering bottom line profitability to shareholders." Financial highlights for the three months ended J.